Upstream Bio Inc Asset Turnover Ratio (UPB), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Upstream Bio Inc   (NASDAQ: UPB)
 

Upstream Bio Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Upstream Bio Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.01 in the first quarter (Mar 31 2026)

Within sector 126 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the I Quarter 2026, to 2455, from total ranking in the fourth quarter 2025 at 3412.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

UPB Asset Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Asset Change -30.27 % -26.55 % 67.44 % 167.78 % -
Y / Y Revenue Change 82.69 % 8.97 % 12.52 % 83.73 % -11.56 %
Asset Turnover Ratio (TTM) 0.01 0.01 0.01 0.01 0.01
UPB's Total Ranking # 2455 # 3412 # 1751 # 3036 # 0
Seq. Asset Change -10.09 % -9.57 % -6.97 % -7.82 % -5.3 %
Seq. Revenue Change 54.79 % -2.2 % -27.11 % 65.55 % -7.67 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 127
Healthcare Sector # 402
Overall Market # 2455

Asset Turnover Ratio Statistics
High Average Low
5.69 4.67 4
(Jun 30 2025)   (Mar 31 2026)




UPB Company Profile • Back to UPB Efficiency Comparisons • Compare UPB Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Assets at quarter ending Mar 31 2026
Dbv Technologies S a   0.03 $ 5.783  Millions$ 209.755  Millions
Northwest Biotherapeutics Inc  0.03 $ 1.497  Millions$ 55.374  Millions
Onkure Therapeutics Inc   0.03 $ 2.816  Millions$ 104.929  Millions
Atrium Therapeutics Inc   0.03 $ 36.817  Millions$ 1,438.386  Millions
Eyepoint Inc   0.03 $ 7.614  Millions$ 301.264  Millions
Mangoceuticals Inc   0.02 $ 0.415  Millions$ 16.978  Millions
Uniqure N v   0.02 $ 18.093  Millions$ 769.222  Millions
Co diagnostics Inc   0.02 $ 0.718  Millions$ 34.362  Millions
Anteris Technologies Global Corp   0.02 $ 1.851  Millions$ 94.168  Millions
Fate Therapeutics Inc   0.02 $ 6.316  Millions$ 329.789  Millions
Bioxcel Therapeutics Inc   0.02 $ 0.680  Millions$ 37.381  Millions
Vistagen Therapeutics Inc   0.02 $ 1.269  Millions$ 70.690  Millions
Envoy Medical Inc   0.02 $ 0.234  Millions$ 14.115  Millions
Aim Immunotech Inc   0.02 $ 0.094  Millions$ 5.998  Millions
Alumis inc   0.02 $ 8.402  Millions$ 545.617  Millions
Rallybio Corporation  0.01 $ 0.858  Millions$ 58.849  Millions
Entrada Therapeutics Inc   0.01 $ 5.738  Millions$ 393.644  Millions
Crinetics Pharmaceuticals Inc   0.01 $ 18.069  Millions$ 1,253.296  Millions
Bellevue Life Sciences Acquisition Corp  0.01 $ 2.526  Millions$ 176.533  Millions
Ataibeckley Inc   0.01 $ 3.488  Millions$ 246.656  Millions
Vyne Therapeutics Inc   0.01 $ 0.535  Millions$ 39.294  Millions
Medicinova Inc   0.01 $ 0.597  Millions$ 46.428  Millions
Prime Medicine Inc   0.01 $ 4.034  Millions$ 325.371  Millions
Vivosim Labs Inc   0.01 $ 0.131  Millions$ 10.925  Millions
Rafael Holdings Inc  0.01 $ 1.131  Millions$ 104.893  Millions
Silo Pharma Inc  0.01 $ 0.072  Millions$ 6.915  Millions
Upstream Bio Inc   0.01 $ 3.322  Millions$ 370.886  Millions
Absci Corp  0.01 $ 1.836  Millions$ 216.693  Millions
Cardiff Oncology Inc   0.01 $ 0.525  Millions$ 62.644  Millions
Nakamoto Inc   0.01 $ 3.920  Millions$ 513.420  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.